Pacira reported $1.93M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Astellas Pharma JPY 4.12B 2.94B Mar/2024
Cara Therapeutics USD 347K 74K Mar/2025
Heron Therapeutics USD 433K 277K Dec/2021
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
J&J USD 2.27 0.13 Jun/2026
Ligand Pharmaceuticals USD 6.65M 262K Mar/2026
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 1.93M 365K Mar/2026
Pfizer USD -0.04 115M Jun/2026
Supernus Pharmaceuticals USD 2.38M 359K Mar/2026
Xeris Pharmaceuticals USD 1.2M 44K Mar/2026
Zoetis USD 21M 4M Mar/2026